1. Home
  2. PLX vs ISSC Comparison

PLX vs ISSC Comparison

Compare PLX & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLX
  • ISSC
  • Stock Information
  • Founded
  • PLX 1993
  • ISSC 1988
  • Country
  • PLX United States
  • ISSC United States
  • Employees
  • PLX N/A
  • ISSC N/A
  • Industry
  • PLX Biotechnology: Biological Products (No Diagnostic Substances)
  • ISSC EDP Services
  • Sector
  • PLX Health Care
  • ISSC Technology
  • Exchange
  • PLX Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • PLX 122.6M
  • ISSC 106.9M
  • IPO Year
  • PLX 1998
  • ISSC 2000
  • Fundamental
  • Price
  • PLX $1.54
  • ISSC $13.54
  • Analyst Decision
  • PLX Strong Buy
  • ISSC
  • Analyst Count
  • PLX 1
  • ISSC 0
  • Target Price
  • PLX $15.00
  • ISSC N/A
  • AVG Volume (30 Days)
  • PLX 1.2M
  • ISSC 293.7K
  • Earning Date
  • PLX 08-13-2025
  • ISSC 08-08-2025
  • Dividend Yield
  • PLX N/A
  • ISSC N/A
  • EPS Growth
  • PLX N/A
  • ISSC 68.61
  • EPS
  • PLX 0.05
  • ISSC 0.61
  • Revenue
  • PLX $59,764,000.00
  • ISSC $65,055,384.00
  • Revenue This Year
  • PLX $65.02
  • ISSC $49.65
  • Revenue Next Year
  • PLX $57.34
  • ISSC $18.61
  • P/E Ratio
  • PLX $31.98
  • ISSC $22.94
  • Revenue Growth
  • PLX 0.18
  • ISSC 58.67
  • 52 Week Low
  • PLX $0.82
  • ISSC $5.25
  • 52 Week High
  • PLX $3.10
  • ISSC $14.72
  • Technical
  • Relative Strength Index (RSI)
  • PLX 47.41
  • ISSC 71.54
  • Support Level
  • PLX $1.32
  • ISSC $13.45
  • Resistance Level
  • PLX $1.67
  • ISSC $14.37
  • Average True Range (ATR)
  • PLX 0.11
  • ISSC 0.74
  • MACD
  • PLX 0.04
  • ISSC 0.02
  • Stochastic Oscillator
  • PLX 62.86
  • ISSC 81.11

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: